J Chem Crystallogr
7. Bilgin AA, Palaska E, Sunal R (1993) Studies on the synthesis
and antidepressant activity of some 1-thiocarbamoyl-3,5-
diphenyl-2-pyrazolines. Arzneimittelforschung 43(10):1041–
1044
8. Cetin A, Cansiz A, Digrak M (2003) 3-Aryl-5-furylpyrazolines
and their biological activities. Heteroat Chem 14(4):345–347
9. Wu H, Feng JT, Lin KC, Zhang X (2012) Synthesis and herbi-
cidal activity of substituted pyrazole isothiocyanates. Molecules
17:12187–12196
Conclusion
In this study we have demonstrated the results of
experimental single crystal X-ray diffraction, molecular
confirmation by Gaussion09, quantification of inter-
molecular interactions by Hirshfeld surface analysis,
Molecular Electrostatic Potential (MEP) calculation at
B3LYP/6-311 G (d,p) level and the lattice energy cal-
culation by PIXELC for the two derivatives of 2,3,5
10. Hashioka S, McLarnon JG, Ryu JK, Youssef AM, Abd-El-Aziz
AS, Neeland EG, Klegeris A (2011) Pyrazole compound
2-MBAPA as a novel inhibitor of microglial activation and
trisubstituted
pyrazoles:(3-(4-hydroxyphenyl)-5-phenyl-
neurotoxicity in vitro and in vivo.
27(3):531–541
J Alzheimers Dis
4,5-dihydro-1H-pyrazol-1-yl)(pyridin-3-yl)methanone (II)
(3-(4-hydroxyphenyl)-5-o-tolyl-4,5-dihydro-1H-pyrazol-1-
yl)(pyridin-3-yl)methanone (II). The single crystal XRD
studies of these two compounds reveal the crystallo-
graphic properties and the optimized structures from the
quantum mechanical study agree with the experimental
structures with the slight deviation in RMSD value of
11. Malla Reddy V, Ravinder Reddy K (2010) Synthesis and antimi-
crobial activity of some novel 4-(1H-benz[d]imidazol-2yl)-1,3-thi-
azol-2-amines. Chem Pharm Bull (Tokyo) 58(7):953–956
12. Govindaraju M, Mylarappa BN, Ajay Kumar K (2013) Synthesis
of novel pyrazole derivatives and their efficacy as antimicrobial
agents’’. Int J Pharm Pharm Sci 5(4):734–737
13. Desiraju GR (1997) Designer crystals: intermolecular interac-
tions, network structures and supramolecular synthons. Chem
Commun 16:1475–1482
˚
0.5051 and 0.6305 A respectively for I and II which
may be due to the changes in the phase. The single
crystal XRD studies along with the Hirshfeld surface
analysis and PIXELC signify that both the strong O–
HÁÁÁN and weak C–HÁÁÁO hydrogen bonds are playing
major role in intermolecular interactions in the pyrazole
derivatives for the supramolecular assembly by providing
maximum stability. These studies about the pyrazole
derivatives will help to design and synthesise new
pyrazole derivatives by modifying the acceptor/donor
atoms or by substitution with new functional groups to
give the different binding strengths to the binding partner
such as proteins.
14. Gautam STD (1999) The weak hydrogen bond in structural
chemistry and biology. Oxford University Press/International
Union of Crystallography, Oxford
15. Desiraju GR (2005) C–HÁÁÁO and other weak hydrogen bonds.
From crystal engineering to virtual screening. Chem Commun
24:2995–3001
16. Nangia A, Desiraju GR (1999) Pseudopolymorphism: occur-
rences of hydrogen bonding organic solvents in molecular crys-
tals. Chem Commun 7:605–606
17. Munshi P, Row TNG (2005) Exploring the lower limit in
hydrogen bonds: analysis of weak C-HÁÁÁO and C-HÁÁÁp inter-
actions in substituted coumarins from charge density analysis.
J Phys Chem A 109:659–672
18. Shukla R, Shripanavar C, Chopra D, Sg B (2015) Quantitative
analysis of intermolecular interactions in the crystal structure of
4-(2-(ethoxymethyl) phenyl)-1Hpyrazol-3-ol. Struct Chem Crys-
tallogr Commun 1(1):1–8
19. Spackman MA, Jayatilaka D (2009) Hirshfeld surface analysis.
CrystEngComm 11(1):19–32
References
20. Montiel S (2015) Crystal structure and hirshfeld surface analysis of
1,2-bis((2-(bromomethyl)phenyl)thio)ethane and two polymorphs
of 1,2-bis((2-((pyridin-2-ylthio)methyl)phenyl)thio)ethane. Mod
Chem Appl 03(02):1–7
1. Nauduri D, Reddy GB (1998) Antibacterials and antimycotics:
part 1: synthesis and activity of 2-pyrazoline derivatives. Chem
Pharm Bull (Tokyo) 46(8):1254–1260
2. Azarifar D, Shaebanzadeh M (2002) Synthesis and characteri-
zation of new 3,5-dinaphthyl substituted 2-pyrazolines and study
of their antimicrobial activity. Molecules 7(12):885–895
3. Kuroda T, Suzuki F, Tamura T, Ohmori K, Hosoe H (1992) A
novel synthesis and potent antiinflammatory activity of 4-hy-
droxy-2(1H)-oxo-1-phenyl-1,8-naphthyridine-3-carboxamides. J
Med Chem 35:1130–1136
4. Zhang C-Y, Liu X-H, Wang B-L, Wang S-H, Li Z-M (2010)
Synthesis and antifungal activities of new pyrazole derivatives
via 1,3-dipolar cycloaddition reaction. Chem Biol Drug Des
75(5):489–493
21. Panini P, Mohan TP, Gangwar U, Sankolli R, Chopra D (2013)
Quantitative crystal structure analysis of 1,3,4-thiadiazole
derivatives. CrystEngComm 15(22):4549
22. Spackman MA, McKinnon JJ (2002) Fingerprinting intermolec-
ular interactions in molecular crystals. CrystEngComm 4(66):378
23. Wolff D, Grimwood DJ, McKinnon JJ, Turner MJ, Jayatilaka
MA, Spackman MA (2012) CrystalExplorer (Version 3.1).
University of Western Australia, Crawley
24. McKinnon JJ, Spackman MA, Mitchell AS (2004) Novel tools for
visualizing and exploring intermolecular interactions in molecu-
lar crystals. Acta Crystallogr B 60(6):627–668
5. Ochi T, Jobo-Magari K, Yonezawa A, Matsumori K, Fujii T
(1999) Anti-inflammatory and analgesic effects of a novel pyra-
zole derivative. Eur J Pharmacol 365(2–3):259–266
6. Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, Lee
KH (1997) Antitumor agents. 178. Synthesis and biological
evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as
antitumor agents that inhibit tubulin polymerization. J Med Chem
40(97):3049–3056
25. Wood PA, Francis D, Marshall WG, Moggach SA, Parsons S,
Pidcock E, Rohl AL (2008) A study of the high-pressure
polymorphs of L-serine using ab initio structures and PIXEL
calculations. CrystEngComm 10:1154–1166
26. Vologzhanina AV, Korlyukov AA, Avdeeva VV, Polyakova
IN, Malinina EA, Kuznetsov NT (2013) Theoretical QTAIM,
ELI-D, and hirshfeld surface analysis of the Cu-(H)B interac-
tion in [Cu2(bipy)2B10H10]. J Phys Chem A 117:13138
123